Browse by category

Results from the Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron, an investigational oral glucagon-like...

GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss,...

A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo metabolic and bariatric surgery (MBS)...

A study led by investigators at Mass General Brigham has found that adding semaglutide and tirzepatide to usual care represents a...

Individuals who are taking semaglutide for weight loss experience less food noise than before, according to research presented at the...

Some individuals who are taking Ozempic, Wegovy or Mounjaro find that foods taste sweeter or saltier than before, according to research...

An international team of researchers led by Icahn School of Medicine at Mount Sinai and the University of Copenhagen in Denmark has...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved an update to Novo Nordisk’s...

Roux-en-Y gastric bypass (RYGB) is effective in men with obesity, demonstrating substantial excess weight loss and significant long-term...

A higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and related health outcomes in adults living with...